HealthcareMachine Learning4 min reading time

INmune Bio and Quantum Computing partner to apply quantum optimization and AI to advance Alzheimer’s drug research and explore new applications for XPro

The Next Web
Read the full article
INmune Bio partners with Quantum Computing Inc. to use quantum optimization and AI for advancing Alzheimer’s drug XPro research and identifying new treatment applications. This marks QCi's first commercial foray into pharma and biotech markets.

More in Healthcare

Healthcare2 min read

Nvidia, worth $5.5tn, donates $250m to UK for AI safety research

Covered by 4 sources
Healthcare3 min read

Patients' frustration at GP surgery's AI receptionist

BBC
Healthcare5 min read

Illumina Debuts BioInsight Platform Unifying AI, Software, and Data

Unite.AI